These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37590975)

  • 1. Alleviation of adipose-hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-κB/NLRP3 repression.
    Olaniyi K; Areloegbe S
    Can J Physiol Pharmacol; 2023 Dec; 101(12):630-641. PubMed ID: 37590975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE
    J Steroid Biochem Mol Biol; 2023 Jan; 225():106179. PubMed ID: 36150640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3.
    Olaniyi KS; Areloegbe SE
    Nutrition; 2023 Mar; 107():111914. PubMed ID: 36521396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE
    Life Sci; 2022 Jul; 300():120560. PubMed ID: 35452635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.
    Olaniyi KS; Areloegbe SE; Oyeleke MB
    Endocrine; 2022 Dec; 78(3):628-640. PubMed ID: 36114434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model.
    Areloegbe SE; Peter MU; Oyeleke MB; Olaniyi KS
    BMC Endocr Disord; 2022 Sep; 22(1):224. PubMed ID: 36071485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation.
    Wolugbom JA; Areloegbe SE; Olaniyi KS
    Mol Neurobiol; 2023 Jan; 60(1):355-368. PubMed ID: 36269541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2.
    Olaniyi KS; Areloegbe SE
    J Physiol Sci; 2024 Apr; 74(1):22. PubMed ID: 38561673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE; Areola ED; Sabinari IW; Fafure AA; Agbana RD; Atuma CL; Shah MZUH; Ajadi IO; Olatunji LA
    Toxicol Appl Pharmacol; 2023 Aug; 473():116604. PubMed ID: 37328115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model.
    Peter MU; Areloegbe SE; Akintayo CO; Oniyide AA; Aturamu A; Olaniyi KS
    Can J Physiol Pharmacol; 2022 Sep; 100(9):890-902. PubMed ID: 35771488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model.
    Olaniyi KS; Bashir AM; Areloegbe SE; Sabinari IW; Akintayo CO; Oniyide AA; Aturamu A
    PLoS One; 2022; 17(7):e0272124. PubMed ID: 35881588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesencephalic astrocyte-derived neurotrophic factor ameliorates inflammatory response in polycystic ovary syndrome via inhibiting TLR4-NF-κB-NLRP3 pathway.
    Yu S; Hou C; Zhang X; Wei Z
    Biochem Biophys Res Commun; 2024 May; 707():149782. PubMed ID: 38493745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1.
    Bashir AM; Olaniyi KS
    BMC Pharmacol Toxicol; 2023 Oct; 24(1):48. PubMed ID: 37789355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway.
    Ma X; Li X; Ma L; Chen Y; He S
    Bioengineered; 2021 Dec; 12(1):7215-7223. PubMed ID: 34546841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways.
    Moustafa PE; Abo El Nasr NME; Shabana ME; Saleh DO
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38789632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation.
    Shao YY; Chang ZP; Cheng Y; Wang XC; Zhang JP; Feng XJ; Guo YT; Liu JJ; Hou RG
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30573529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.
    Mu J; Cheng F; Wang Q; Wang X; Zhu W; Ma C; Yin X; Ren B; Lian Y; Du X; Zhang H; Liu S; Zhang S
    J Tradit Chin Med; 2020 Apr; 40(2):253-266. PubMed ID: 32242391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder.
    Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
    Eur J Pharmacol; 2017 Aug; 809():141-150. PubMed ID: 28526339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of berberine on LPS /NF-κB and MAPK signaling pathways in PCOS model rats].
    Zhao FQ; Zhao Y; Liu JY; Gou YJ; Yang YQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Mar; 38(2):181-186. PubMed ID: 36031579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.